China Online Drug Sellers Blossom Despite Regulatory Hold
This article was originally published in PharmAsia News
While the regulators debate and a proposed regulation is put on hold, entrepreneurs are rushing to sign up pharmacies and upgrade sales services in a race to capture a slice of China’s potentially huge online drug market.
You may also be interested in...
Podcast: Living In China's Coronavirus Lockdown; Novartis and England's 'Public Health' Alliance; Biogen's Moment of Truth Approaches
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.
Amid the ongoing spread of the coronavirus outbreak, China turns to novel and repurposed antiviral drugs but also courts traditional medicines to ease public fear over the largely unknown threat.